ALTUVOCT

This brand name is authorized in Austria, France, Lithuania, Romania

Active ingredients

The drug ALTUVOCT contains one active pharmaceutical ingredient (API):

1 Efanesoctocog alfa UNII WH7BHQ0RB4 - EFANESOCTOCOG ALFA

Efanesoctocog alfa or recombinant coagulation Factor VIII Fc-Von Willebrand Factor-XTEN is a recombinant fusion protein that temporarily replaces the missing coagulation Factor VIII needed for effective haemostasis. Read about Efanesoctocog alfa

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 60110654, 60495577, 64317020, 66258503, 67263268, 68225911, 68896821
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1100035, 1100036, 1100037, 1100038, 1100039, 1100040, 1100041
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W70515001, W70516001, W70517001, W70518001, W70519001, W70520001, W70521001